Uchenna Iyioku Ugah, Theophilus Kachidelu Udeani


Background: Carbapenems are broad spectrum β-lactam antibiotics that were introduced in response to the emergence of ESBL-producing Gram-negative bacteria. This study aimed at determining the occurence of carbapenem resistant Enterobacterales isolates among patients attending five tertiary hospitals with southeastern region of Nigeria.

Methods: A total of 400 Enterobacterales were isolated from different participants. Carbapenem-resistance was detected using Kirby-Bauer disc diffusion method with ertapenem, meropenem, imipenem, and doripenem.

Results:  A total of 117 isolates (29.2%) were resistant to the four carbapenems. When compared among the states, the prevalence were 33.6%, 29.1%, 28.8%, 26.9% and 24.7% for Enugu, Ebonyi, Imo, Anambra and Abia states respectively. The highest resistance was observed among P. mirabilis (52.6%) followed by K. oxytoca (35.7%), S. enterica (35.7%) and K. pneumoniae (33.8%).

Conclusion:  The overall prevalence was high and this is a cause for concern and urgent need for emergency intervention to forestall widespread emergence of pandrug resistant infections.


Carbapenem, Enterobacterales, Southeast-Nigeria

Full Text:



Olowo-Okere A, Abdullahi MA, Ladidi BK, Suleiman S, Tanko N, Ungokore HY, et al. Emergence of metallo-β-lactamase producing Gram-negative bacteria in a hospital with no history of carbapenem usage in Northwest Nigeria. Ife J Sc 2019;21(2):323-31.

Iovleva A and Doi Y. Carbapenem-resistant Enterobacteriaceae. Clin Lab Med 2017;37(2):303-15.

Logan LK and Weinstein RA. The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis 2017;215:28-36.

Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. Centers for Disease Control and Prevention, US Department of Health and Human Services, 2013 [retrieved 2020 May 25]. Available online at

Guh AY, Bulens SN, Mu Y, Jacob JT, Reno J Scott J Kallen AJ. Epidemiology of carbapenem-resistant Enterobacteriaceae in 7 US Communities, 2012-2013. JAMA 2015;314(14):1479-87.

Anibijuwon II, Gbala ID, Adebisi OO. Carbapenem-resistant Enterobacteriaceae among in-patients of tertiary hospitals in Southwest, Nigeria. Not SciBiol 2018;10(3):310-17.

Ciftci E, Cetin ES, Us E, Kutlu HH, Aridogan BC. Investigation of carbapenem resistance mechanisms in Klebsiella pneumoniae by using phenotypic tests and a molecular assay. J Infect Dev Ctries 2019;13(11):992-1000.

Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011;17:1791-8.

Oli AN, Itumo CJ, Okam PC, Ezebialu IU, Okeke KN, Ifezulike CC, et al. Carbapenem-resistant Enterobacteriaceae posing a dilemma in effective healthcare delivery. Antibiotics 2019;8:156-66.

Yusuf I, Rabiu AT, Haruna M, Abdullahi SA. Carbapenem-resistant Enterobacteriaceae (CRE) in intensive care units and surgical wards of hospitals with no history of carbapenem usage in Kano, Northwest Nigeria. Nig J Microb 2015;27(1):2612-18.

Aliyu S. Carbapenemase producing Gram-negative bacteria: an emerging threat to healthcare in Africa. Ann Nig Med 2013;7(1):1-2.

Ssekatawa K, Byarugaba DK, Wampande E, Ejobi FA. Systematic review: the current status of carbapenem resistance in East Africa. BMC Res Notes 2018;11:629-37.

Adelowo OO, Vollmers J, Mausezahl I, Kaster A, Muller JA. Detection of the carbapenemase gene blaVIM-15 in members of the Pseudomonas putida group isolated from polluted Nigerian wetlands. Sci Rep 2018;8:15116.

Okoche D, Asiimwe BB, Katabazi FA, Kato L, Najjuka CF. Prevalence and characterization of carbapenem-resistant Enterobacteriaceae isolated from Mulago National Referral Hospital, Uganda. PLoS ONE 2015;10(8): e0135745.

Cheesbrough M. District Laboratory Practice in Tropical countries. Part 2. Cambridge University Press. Cambridge, United Kingdom. 2002. ISBN: 0-521-66546-9.

Forbes BA, Sahm DF, and Weissfeld AS. Bailey and Scott's Diagnostic Microbiology, 12th ed. Mosby Elsevier: St. Louis, Missouri, USA; 2007.

European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint Tables for Interpretation of MICs and zone diameters version 10. 2020. Available at

Mohammed Y, Zailani SB, Onipede AO, Galadima BG, Ibrahim BS, Manga MM, et al. Comparison of three phenotypic methods for the screening of carbapenem resistance among clinical isolates of Enterobacteriaceae. Sub-SAfr J Med2018;5:10-14.

Adesanya OA, Igwe HA. Carbapenem-resistant Enterobacteriaceae (CRE) and gram-negative bacterial infections in south-west Nigeria: a retrospective epidemiological surveillance study. AIMS Pub Health 2020 Oct 16;7:804-15.

Ajuba IM, Akujobi CN, Aghanya IN, Ushie SN, Okoro AE, Ofiaeli RO, et al. Emergence of New-Delhi Metallo-betalactamase-1- and Oxacillinase-48 positive Escherichia coli in South Eastern Nigeria. Niger J Med 2020;9:701-6.

Aminu A, Daneji IM, Yusuf MA, Jalo RI, Tsiga-Ahmed FI, Yahaya M, et al. Carbapenem-resistant Enterobacteriaceae infections among patients admitted to intensive care units in Kano, Nigeria. Sahel Med J 2021;24:1-9

Mohammed Y, Zailani SB, Onipede AO. Characterization of KPC, NDM and VIM type carbapenem resistance Enterobacteriaceae from North-Eastern Nigeria. J Bio Med 2015; 3:100-107.

Oduyebo OO, Falayi OM, Oshu P, Ettu AO. Phenotypic determination of carbapenemase producing Enterobacteriaceae isolates from clinical specimens at a tertiary hospital in Lagos, Nigeria. Nig Post Med J 2015;22:223-7.

Ngbede EO, Adekanmbi F, Poudel A, Kalalah A, Kelly P, Yang Y, et al. Concurrent resistance to carbapenem and colistin among enterobacteriaceae recovered from human and animal sources in Nigeria is associated with multiple genetic mechanisms. Front Microbiol 2021;12:740348.

Badmasti F, Omid A, Mohammad A.M, Hamid S. Data on the prevalence and distribution of carbapenemase genes in Enterobacterales species isolated from clinical specimens in the center of Irans. Data in Brief 2021;38:107368.

Barbadoro P, Bencardino D, Carloni E, Omiccioli E, Ponzio E, et al. Carriage of carbapenem-resistant enterobacterales in adult patients admitted to a university hospital in Italy. Antibiotics (Basel) 2021;10(1):61.

Wilson GM, Suda KJ, Fitzpatrick MA, Bartle B, Pfeiffer CD, Jones M, et al. QUERI CARRIAGE Program, risk factors associated with carbapenemase-producing carbapenem-resistant enterobacteriaceae positive cultures in a cohort of US Veterans. Clin Infect Dis 2021;73(8):1370-8.



  • There are currently no refbacks.

Copyright (c) 2022. Uchenna Iyioku Ugah, Theophilus Kachidelu Udeani

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.